About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Kringle Pharma,Inc.(4884) Summary

4884
TSE Growth
Kringle Pharma,Inc.
809
JPY
-1
(-0.12%)
Dec 23, 3:30 pm JST
5.16
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
2.64
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
810 JPY 5.17 USD
Previous Close Dec 20
810 JPY 5.16 USD
High Dec 23, 1:21 pm
836 JPY 5.34 USD
Low Dec 23, 9:14 am
798 JPY 5.10 USD
Volume
69,900
Trading Value
0.06B JPY 0.36M USD
VWAP
814.17 JPY 5.2 USD
Minimum Trading Value
80,900 JPY 516 USD
Market Cap
5.51B JPY 0.04B USD
Number of Trades
236
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
Slightly High
1-Year Average
532
1-Year High Jun 27, 2024
12,293
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 0 817,400
Dec 6, 2024 0 841,500
Nov 29, 2024 0 856,600
Nov 22, 2024 0 878,200
Nov 15, 2024 0 929,000
Company Profile
Kringle Pharma, Inc. is engaged in the research and development of therapeutic drugs for intractable diseases using HGF protein.
Sector
Pharmaceuticals